[Insulin-sensitizing agents].
暂无分享,去创建一个
[1] J. Olefsky. Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists , 2000 .
[2] H. Ginsberg. Insulin resistance and cardiovascular disease. , 2000, The Journal of clinical investigation.
[3] A. Golay,et al. Metformin treatment leads to an increase in basal, but not insulin‐stimulated, glucose disposal in obese patients with impaired glucose tolerance , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[4] K. Eriksson,et al. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise , 1998, Diabetologia.
[5] B. Howard,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.
[6] B. Ludvik,et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. , 1994, The New England journal of medicine.
[7] G. Sartor,et al. Ten-year Follow-up of Subjects with Impaired Glucose Tolerance: Prevention of Diabetes by Tolbutamide and Diet Regulation , 1980, Diabetes.